Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Galea

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|August 7, 2021
Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorderMatt Butler, Arina Tamborska, Greta K Wood, et al.
Clinical and Translational Medicine|July 9, 2022
Zonulin and blood-brain barrier permeability are dissociated in humansCharlotte M Stuart, Aravinthan Varatharaj, Martin E Winberg, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Blood-brain barrier permeability changes in the first year after alemtuzumab treatment predict 2-year outcomes in relapsing-remitting multiple sclerosisMaria Højberg Knudsen, Ulrich Lindberg, Jette Lautrup Frederiksen, et al.
Plos One|November 30, 2018
Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international surveyAndrea Giordano, Katrin Liethmann, Sascha Köpke, et al.
Brain : a Journal of Neurology|June 1, 2010
N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexesSarosh R Irani, Katarzyna Bera, Patrick Waters, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2016
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLCEdurne Arriola, Matthew Wheater, Ian Galea, et al.
International Journal of Molecular Sciences|March 13, 2024
A Systematic Review and Meta-Analysis of the Pathology Underlying Aneurysm Enhancement on Vessel Wall ImagingRonneil Digpal, Kenton P Arkill, Regan Doherty, et al.
The Journal of Infectious Diseases|September 29, 2025
Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and TherapiesSarah A Boardman, Claire Hetherington, Thomas Hughes, et al.
Frontiers in Aging Neuroscience|April 7, 2022
Association of Haptoglobin Phenotype With Neurological and Cognitive Outcomes in Patients With Subarachnoid HemorrhageSung Woo Han, Bong Jun Kim, Tae Yeon Kim, et al.
Glia|April 23, 2005
CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentationBabs O Fabriek, Elise S Van Haastert, Ian Galea, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Journal of Neurology, Neurosurgery, and Psychiatry|August 7, 2021
Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorderMatt Butler, Arina Tamborska, Greta K Wood, et al.
Clinical and Translational Medicine|July 9, 2022
Zonulin and blood-brain barrier permeability are dissociated in humansCharlotte M Stuart, Aravinthan Varatharaj, Martin E Winberg, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Blood-brain barrier permeability changes in the first year after alemtuzumab treatment predict 2-year outcomes in relapsing-remitting multiple sclerosisMaria Højberg Knudsen, Ulrich Lindberg, Jette Lautrup Frederiksen, et al.
Plos One|November 30, 2018
Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international surveyAndrea Giordano, Katrin Liethmann, Sascha Köpke, et al.
Brain : a Journal of Neurology|June 1, 2010
N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexesSarosh R Irani, Katarzyna Bera, Patrick Waters, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2016
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLCEdurne Arriola, Matthew Wheater, Ian Galea, et al.
International Journal of Molecular Sciences|March 13, 2024
A Systematic Review and Meta-Analysis of the Pathology Underlying Aneurysm Enhancement on Vessel Wall ImagingRonneil Digpal, Kenton P Arkill, Regan Doherty, et al.
The Journal of Infectious Diseases|September 29, 2025
Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and TherapiesSarah A Boardman, Claire Hetherington, Thomas Hughes, et al.
Frontiers in Aging Neuroscience|April 7, 2022
Association of Haptoglobin Phenotype With Neurological and Cognitive Outcomes in Patients With Subarachnoid HemorrhageSung Woo Han, Bong Jun Kim, Tae Yeon Kim, et al.
Glia|April 23, 2005
CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentationBabs O Fabriek, Elise S Van Haastert, Ian Galea, et al.
Pageof 12